JFS Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

JFS Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.91K	Hold	270	–	–	﹤0.01%	1380
2026 Q1	$3.74K	Sell	270 -477	-64%	-$6.64K	﹤0.01%	1294
2025 Q4	$10.5K	Hold	747	–	–	﹤0.01%	956
2025 Q3	$10.4K	Hold	747	–	–	﹤0.01%	884
2025 Q2	$11.2K	Buy	747 +102	+16%	+$1.46K	﹤0.01%	831
2025 Q1	$8.51K	Sell	645 -245	-28%	-$3.38K	﹤0.01%	930
2024 Q4	$14.1K	Hold	890	–	–	﹤0.01%	749
2024 Q3	$14.1K	Hold	890	–	–	﹤0.01%	736
2024 Q2	$13.6K	Hold	890	–	–	﹤0.01%	699
2024 Q1	$13.1K	Buy	890 +245	+38%	+$3.58K	﹤0.01%	735
2023 Q4	$8.98K	Sell	645 -65	-9%	-$869	﹤0.01%	808
2023 Q3	$9.5K	Buy	710 +65	+10%	+$879	﹤0.01%	750
2023 Q2	$8.14K	Hold	645	–	–	﹤0.01%	796
2023 Q1	$7.34K	Hold	645	–	–	﹤0.01%	836
2022 Q4	$6.68K	Sell	645 -300	-32%	-$3.24K	﹤0.01%	872
2022 Q3	$10K	Buy	945 +365	+63%	+$3.89K	﹤0.01%	734
2022 Q2	$6K	Buy	580 +260	+81%	+$2.83K	﹤0.01%	954
2022 Q1	$4K	Buy	320 +200	+167%	+$2.27K	﹤0.01%	1168
2021 Q4	$2K	Buy	+120	New	+$1.51K	﹤0.01%	1143

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JFS Wealth Advisors's RDY Position: Q2 2026 in Review

JFS Wealth Advisors held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 270 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #1380.

JFS Wealth Advisors first reported a position in RDY in Q4 2021 and has held it in 19 quarters since. The position peaked at $14.1K in Q3 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

JFS Wealth Advisors held 270 shares of Dr. Reddy's Laboratories worth $3.91K as of Q2 2026.
JFS Wealth Advisors left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1380 holding.
JFS Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2021 and has held it in 19 quarters since.
JFS Wealth Advisors's Dr. Reddy's Laboratories position peaked at $14.1K in Q3 2024.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.